Benson Musinguzi

Mr. Benson Musinguzi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
PDF file
INIsrael Kiiza Njovu
Israel Kiiza Njovu
BMBenson Musinguzi
Benson Musinguzi
JMJames Mwesigye
James Mwesigye
KKKennedy Kassaza
Kennedy Kassaza
JTJoseph Turigurwa
Joseph Turigurwa
HIHerbert Itabangi
Herbert Itabangi
Pulmonary mycoses are important diseases of the respiratory tract caused by pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and mortality rates worldwide; however, less attention has been paid to them. In this study we determined the prevalence of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara Regional Referral Hospital. This was a hospital based cross sectional survey. Sputum samples were collected from each study participant. For each sample, the following tests were performed: Sabouraud dextrose agar for fungal culture, GeneXpert for Mycobacteria tuberculosis (MTB) and potassium hydroxide for fungal screening. Filamentous fungal growth and yeasts were further examined with lactophenol cotton blue staining and germ tube respectively. Out of 113 study participants, 80 (70.7%) had pulmonary fungal pathogens whilst those with pulmonary tuberculosis numbered five (4.4%). Candida albicans [21 (22.58%)] and Aspergillus species [16 (17.20%)] were the pathogens most identified among others. Two (1.7%) TB GeneXpert positive participants had fungal pathogens isolated from their sputum samples. We established a prevalence of 57 (71.3%) for pulmonary fungal pathogen (PFP) isolates, three (60.0%) for MTB in HIV positive patients and 18 (22.5%) for PFP, and zero (0.0%) for MTB in HIV negative patients. On the other hand, two (100%) HIV positive patients had both PFP isolates and MTB. Our findings highlight the diversity of neglected pulmonary fungal pathogens whose known medical importance in causing pulmonary mycoses cannot be overemphasised. Therefore this presents a need for routine diagnosis for pulmonary mycoses among TB suspects and set-up of antimicrobial profile for pulmonary fungal isolates to support clinical management of these cases.

19 November 2025 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
EMEdson Mwebesa
Edson Mwebesa
BMBenson Musinguzi
Benson Musinguzi
ILIsmail D. Legason
Ismail D. Legason
RORobert Opoke
Robert Opoke
BABosco B. Agaba
Bosco B. Agaba
AMAnn Mwangi
Ann Mwangi
Introduction: Malaria remains a significant public health challenge among pregnant women in sub-Saharan Africa (SSA). Proper use of insecticide-treated nets (ITNs) is a key intervention for malaria; however, their utilisation remains low and suboptimal in high-burden countries. Investigation of correlates of use of ITNs among pregnant women in only high-burden malaria countries SSA are dearth. This study aimed to identify the pooled prevalence and factors associated with ITNs use among pregnant women in seven malaria high-burden countries in SSA. Methods: Secondary analysis of recent (2017–2021) Malaria Indicator Survey (MIS) data from seven malaria high-burden countries in SSA was utilised. Women aged 15–49 years, who were pregnant during the survey, were included in this study, resulting in a pooled sample size of 4950 women. Pooled prevalence of ITN use was obtained through the use of proportions, with a 95% confidence interval (CI). A multilevel mixed-effect logistic regression model was run to obtain factors associated with ITNs use among pregnant women at 5% level of significance. Data analysis was done in Stata v17.0 and R 4.5.0. Findings: The pooled prevalence of ITNs use among these countries was 63.8 [95% CI 61.8, 65.9], low in Ghana (49.2%) and high in Niger (90.5%). Having a primary level of education [aOR = 1.36, 95% CI 1.21, 1.53] compared to those with no formal education, having given birth to one to two children [aOR = 1.24, 95% CI 1.06, 1.44] compared to those with no births yet were associated with higher odds of ITN use. 14% of the total variation in ITN use was attributable to differences between countries [intra-cluster correlation (ICC) = 0.14, 95% CI 0.06, 0.20] and 32% of the variation in ITN use within countries is attributed to differences between regions [ICC = 0.32, 95% CI 0.21, 0.46]. Conclusions: The prevalence of ITN use was suboptimal, and socio-demographic and household factors are associated with ITN use among pregnant women, with substantial in-country variation underscoring the role of regional context in ITN utilization. These findings suggest that beyond individual and household determinants, local and regional contexts play a critical role in shaping ITN usage patterns. Interventions should, therefore, be tailored not only to socio-demographic profiles but also to regional and local disparities in access, awareness, and implementation effectiveness.

1 January 2024 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
BMBenson Musinguzi
Benson Musinguzi
LTLaban Turyamuhika
Laban Turyamuhika
AMAlex Mwesigwa
Alex Mwesigwa
PNPauline Petra Nalumaga
Pauline Petra Nalumaga
IKImmaculate Kabajulizi
Immaculate Kabajulizi
BABeatrice Achan
Beatrice Achan
Background: Despite the increased frequency of oropharyngeal candidiasis among people living with human immunodeficiency virus (HIV), its management is no longer effective due to empirical treatment and emergence of antifungal resistance (AFR). This study sought to investigate the prevalence of oropharyngeal candidiasis and assess the antifungal susceptibility profile of oropharyngeal Candida species isolated from people living with human immunodeficiency virus. Additionally, we evaluated the correlation between oropharyngeal candidiasis and CD4 T cell as well as viral load counts. Methods: A descriptive cross-sectional study was carried out from April to October 2023 in which 384 people living with HIV underwent clinical examination for oral lesions. Oropharyngeal swabs were collected and cultured on Sabouraud Dextrose agar to isolate Candida species which were identified using the matrix assisted laser desorption ionization time of flight mass spectrometry. Additionally, the antifungal susceptibility profile of Candida isolates to six antifungal drugs was determined using VITEK® (Marcy-l’Étoile, France) compact system. Data on viral load were retrieved from records, and CD4 T cell count test was performed using Becton Dickinson Biosciences fluorescent antibody cell sorter presto. Results: The prevalence of oropharyngeal candidiasis was 7.6%. Oropharyngeal candidiasis was significantly associated with low CD4 T cell count and high viral load. A total of 35 isolates were obtained out of which Candida albicans comprised of 20 (57.1%) while C. tropicalis and C. glabrata comprised 4 (11.4%) each. C. parapsilosis, C. dubliniensis and C. krusei accounted for 2 (5.7%) each. Additionally, 7 (20%) isolates were resistant to fluconazole, 1 (2.9%) to flucytocine and 0.2 (5.7%) isolates were intermediate to caspofungin. However, specific specie isolates like C. albicans showed 20% (4/20), C. glabrata 50% (2/4) and C. krusei 50% (1/2) resistance to fluconazole. Additionally, C. krusei showed 50% resistance to flucytosine. Conclusion: The prevalence of oropharyngeal candidiasis (OPC) among people living with HIV was low, and there was a significant association between OPC and CD4 T cell count as well as viral load. C. albicans was the most frequently isolated oropharyngeal Candida species. C. glabrata and C. krusei exhibited the highest AFR among the non- albicans Candida species. The highest resistance was demonstrated to fluconazole.

8 February 2023
Verified
Book Chapter
Open access
BMBenson Musinguzi
Benson Musinguzi
OSObondo J. Sande
Obondo J. Sande
GMGerald Mboowa
Gerald Mboowa
ABAndrew Baguma
Andrew Baguma
HIHerbert Itabangi
Herbert Itabangi
BABeatrice Achan
Beatrice Achan
The burden of Candidiasis continues to increase and so does the Candida species. Although Candida species are closely similar phenotypically, they differ from each other in terms of epidemiology, genetic characteristics, antifungal susceptibility and virulence profile. Therefore, reliable and accurate laboratory methods for identification of Candida species can determine the Candidiasis burden and enable the administration of the most appropriate antifungal drug therapy to reduce fungal mortality rates. Conventional and biochemical methods are often used in identification of Candida species. However, these techniques are specific and sensitive enough in detecting the non albicans candida (NAC) species. Molecular techniques have improved the laboratory diagnosis and management of Candidiasis due to improved sensitivity and specificity threshold. This chapter provides an overview of different laboratory methods for diagnosis of Candidiasis.

14 December 2024 in Microbial Pathogenesis
Verified
Journal Article
Closed access
BMBenson Musinguzi
Benson Musinguzi
AAAndrew Akampurira
Andrew Akampurira
HDHope Derick
Hope Derick
LTLaban Turyamuhika
Laban Turyamuhika
AMAlex Mwesigwa
Alex Mwesigwa
BABeatrice Achan
Beatrice Achan

15 August 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
INIsrael Kiiza Njovu
Israel Kiiza Njovu
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
LALucas Ampaire
Lucas Ampaire
ENEdwin Nuwagira
Edwin Nuwagira
JMJames Mwesigye
James Mwesigye
HIHerbert Itabangi
Herbert Itabangi
Background: Fungal-bacterial cocolonization and coinfections pose an emerging challenge among patients suspected of having pulmonary tuberculosis (PTB); however, the underlying pathogenic mechanisms and microbiome interactions are poorly understood. Understanding how environmental microbes, such as fungi and bacteria, coevolve and develop traits to evade host immune responses and resist treatment is critical to controlling opportunistic pulmonary fungal coinfections. In this project, we propose to study the coexistence of fungal and bacterial microbial communities during chronic pulmonary diseases, with a keen interest in underpinning fungal etiological evolution and the predominating interactions that may exist between fungi and bacteria. Objective: This is a protocol for a study aimed at investigating the metabolic and molecular ecological evolution of opportunistic pulmonary fungal coinfections through determining and characterizing the burden, etiological profiles, microbial communities, and interactions established between fungi and bacteria as implicated among patients with presumptive PTB. Methods: This will be a laboratory-based cross-sectional study, with a sample size of 406 participants. From each participant, 2 sputa samples (one on-spot and one early morning) will be collected. These samples will then be analyzed for both fungal and bacterial etiology using conventional metabolic and molecular (intergenic transcribed spacer and 16S ribosomal DNA–based polymerase chain reaction) approaches. We will also attempt to design a genome-scale metabolic model for pulmonary microbial communities to analyze the composition of the entire microbiome (ie, fungi and bacteria) and investigate host-microbial interactions under different patient conditions. This analysis will be based on the interplays of genes (identified by metagenomics) and inferred from amplicon data and metabolites (identified by metabolomics) by analyzing the full data set and using specific computational tools. We will also collect baseline data, including demographic and clinical history, using a patient-reported questionnaire. Altogether, this approach will contribute to a diagnostic-based observational study. The primary outcome will be the overall fungal and bacterial diagnostic profile of the study participants. Other diagnostic factors associated with the etiological profile, such as incidence and prevalence, will also be analyzed using univariate and multivariate schemes. Odds ratios with 95% CIs will be presented with a statistical significance set at P<.05. Results: The study has been approved by the Mbarara University Research Ethic Committee (MUREC1/7-07/09/20) and the Uganda National Council of Science and Technology (HS1233ES). Following careful scrutiny, the protocol was designed to enable patient enrollment, which began in March 2022 at Mbarara University Teaching Hospital. Data collection is ongoing and is expected to be completed by August 2023, and manuscripts will be submitted for publication thereafter. Conclusions: Through this protocol, we will explore the metabolic and molecular ecological evolution of opportunistic pulmonary fungal coinfections among patients with presumptive PTB. Establishing key fungal-bacterial cross-kingdom synergistic relationships is crucial for instituting fungal bacterial coinfecting etiology. Trial Registration: ISRCTN Registry ISRCTN33572982; https://tinyurl.com/caa2nw69 International Registered Report Identifier (IRRID): DERR1-10.2196/48014